Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

News

Avinger Inc. announced the enrollment of the first European patient in the CONNECT II global clinical trial. The first ...

Home February 27, 2012
Home
News

February 24, 2012 โ€” A new report released today by HealthGrades found that from 2008 to 2010, emergency admissions for ...

Home February 24, 2012
Home
News

February 24, 2012 โ€” CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of ...

Home February 24, 2012
Home
News

February 23, 2012 โ€“ According to a new survey issued by the Heart Rhythm Society (HRS), the majority of Americans are ...

Home February 23, 2012
Home
News

February 16, 2012 โ€” Velomedix Inc., a clinical stage medical device company, received investigational device exemption ...

Home February 16, 2012
Home
Feature

February 15, 2012 โ€” Medtronic Inc. announced the start of two clinical initiatives evaluating the broader, real-world ...

Home February 15, 2012
Home
News

February 6, 2012 โ€” InspireMD Inc. announced positive clinical results for its MGuard stent from a controlled randomized ...

Home February 06, 2012
Home
News

February 6, 2012 โ€” A medical technology company commercializing the world's first and only self-apposing stent to treat ...

Home February 06, 2012
Home
News

February 3, 2012 โ€” Medtronic Inc. issued a statement on the results of two studies evaluating the use of the Medtronic ...

Home February 03, 2012
Home
News

February 2, 2012 โ€” Abiomed Inc. announced that initial clinical data from the safety study for Symphony was presented by ...

Home February 02, 2012
Home
News

January 31, 2012 โ€” Since its launch less than a year ago, more than one million computed tomography (CT) scans have been ...

Home January 31, 2012
Home
News

January 30, 2012 โ€” Medtronic, Inc. announced the completion of patient enrollment in the extreme risk study in its ...

Home January 30, 2012
Home
News

January 30, 2012 โ€” Expanded cholesterol assessment of moderate risk patients can play an important role in identifying ...

Home January 30, 2012
Home
News

January 30, 2012 - The 2012 American College of Cardiology (ACC) meeting in Chicago, March 24-26, includes five sessions ...

Home January 30, 2012
Home
News

January 26, 2012 โ€” Amorcyte LLC, a NeoStem company, announced the enrollment of the first patient in the Amorcyte ...

Home January 26, 2012
Home
Subscribe Now